Skip to main content

Table 1 Patient baseline characteristics

From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

 

Losartan (n = 20)

Telmisartan (n = 20)

P value

Mean ± SD age (years)

56.2 ± 11.0

55.3 ± 12.4

NS

Males/females

11/9

12/8

 

Office blood pressure (mmHg)

   

   Mean ± SD SBP

149.7 ± 9.0

151.3 ± 7.1

 

   Mean ± SD DBP

91.2 ± 7.4

89.8 ± 8.7

 

24-hour mean blood pressure (mmHg)

   

   Mean ± SD SBP

142.8 ± 12.0

143.6 ± 14.0

NS

   Mean ± SD DBP

88.8 ± 10.2

88.3 ± 9.5

NS

Mean ± SD body mass index (kg/m2)

32.1 ± 7.2

34.5 ± 6.3

NS

Impaired glucose tolerance (n)

19

17

NS

Type 2 diabetics (n)

1

3

NS

Metabolic syndrome components (n)a

   

   3

11

10

NS

   4

7

8

NS

   5

2

2

NS

Total cholesterol (mg/dl)

212.6 ± 45.8

209.6 ± 50.8

NS

Low-density lipoprotein cholesterol (mg/dl)

134 ± 44

138 ± 34

NS

High-density lipoprotein cholesterol (mg/dl)

51.2 ± 11

56.3 ± 17

NS

Triglycerides (mg/dl)

221 ± 32

210 ± 23

NS

  1. a Based on World Health Organization criteria [1].